New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Two rare pre-stamp era postal covers originating from Odisha have fetched record prices at…
Bhubaneswar: The Odisha government’s Housing and Urban Development Department has issued an advisory promoting fuel…
Bhubaneswar: The Odisha government is set to introduce a new film policy and establish a…
Bhubaneswar: Commuters travelling by private buses in Odisha will now have to pay slightly higher…
Bhubaneswar: The Odisha government on Friday announced a two per cent hike in dearness allowance…
Namchi: Union Minister Jyotiraditya Scindia on Friday reviewed several key projects related to education, tourism,…
